Frank Park

3.5k total citations
89 papers, 2.8k citations indexed

About

Frank Park is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Frank Park has authored 89 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 34 papers in Genetics and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Frank Park's work include Virus-based gene therapy research (21 papers), RNA Interference and Gene Delivery (11 papers) and Genetic and Kidney Cyst Diseases (10 papers). Frank Park is often cited by papers focused on Virus-based gene therapy research (21 papers), RNA Interference and Gene Delivery (11 papers) and Genetic and Kidney Cyst Diseases (10 papers). Frank Park collaborates with scholars based in United States, South Korea and Japan. Frank Park's co-authors include Mark A. Kay, Kazuo Ohashi, Allen W. Cowley, David L. Mattson, Luigi Naldini, Noriyuki Miyata, Xiao Feng Li, Feng Wu, Quinn H. Hogan and Kevin R. Regner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Frank Park

83 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frank Park United States 30 1.5k 869 444 439 304 89 2.8k
Belén Peral Spain 31 2.2k 1.5× 1.8k 2.1× 276 0.6× 866 2.0× 252 0.8× 53 4.0k
Nicholas Obermüller Germany 28 1.5k 1.0× 736 0.8× 289 0.7× 155 0.4× 242 0.8× 65 2.9k
Osamu Yasuda Japan 26 956 0.6× 251 0.3× 414 0.9× 374 0.9× 237 0.8× 86 2.7k
P. Darwin Bell United States 30 1.3k 0.8× 335 0.4× 529 1.2× 478 1.1× 290 1.0× 56 2.5k
Kazuhiro Oka United States 34 1.9k 1.3× 770 0.9× 463 1.0× 391 0.9× 456 1.5× 74 3.8k
Éva Kiss Germany 33 1.7k 1.2× 243 0.3× 698 1.6× 413 0.9× 296 1.0× 86 4.1k
Robert F. Spurney United States 33 1.8k 1.2× 257 0.3× 481 1.1× 307 0.7× 400 1.3× 82 3.3k
Shinichi Usui Japan 32 1.4k 0.9× 230 0.3× 481 1.1× 280 0.6× 511 1.7× 108 3.7k
Florian Grahammer Germany 35 2.4k 1.6× 446 0.5× 515 1.2× 279 0.6× 450 1.5× 85 4.0k
John Li United States 31 1.3k 0.9× 398 0.5× 337 0.8× 680 1.5× 831 2.7× 82 4.0k

Countries citing papers authored by Frank Park

Since Specialization
Citations

This map shows the geographic impact of Frank Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Park more than expected).

Fields of papers citing papers by Frank Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Park. The network helps show where Frank Park may publish in the future.

Co-authorship network of co-authors of Frank Park

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Park. A scholar is included among the top collaborators of Frank Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Park. Frank Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Park, Frank, et al.. (2025). R-spondin 2 suppresses hepatic steatosis via activation of AMPK-ACC signaling. JHEP Reports. 7(12). 101551–101551. 1 indexed citations
2.
Mandal, Mousumi, Ahmed Rakib, Md Abdullah Al Mamun, et al.. (2024). DJ-X-013 reduces LPS-induced inflammation, modulates Th17/ myeloid-derived suppressor cells, and alters NF-κB expression to ameliorate experimental colitis. Biomedicine & Pharmacotherapy. 179. 117379–117379. 2 indexed citations
3.
Collier, Daniel M., et al.. (2024). Lack of Cannabinoid Type 2 Promoter Activity in Normal or Injured Kidneys Using a Cnr2-GFP Reporter Mouse. Cannabis and Cannabinoid Research. 10(3). 400–408. 1 indexed citations
4.
Cowley, Allen W., Richard J. Roman, David L. Mattson, et al.. (2024). Renal Medulla in Hypertension. Hypertension. 81(12). 2383–2394. 3 indexed citations
5.
Sharma, Bal Krishan, Maxwell A. Gyamfi, Jianxiong Jiang, et al.. (2024). Nidogen 2 Overexpression Promotes Hepatosteatosis and Atherosclerosis. International Journal of Molecular Sciences. 25(23). 12782–12782.
6.
Singla, Bhupesh, Frank Park, Maxwell A. Gyamfi, et al.. (2023). CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 43(7). 1234–1250. 21 indexed citations
7.
Mandal, Mousumi, Ahmed Rakib, Sonia Kiran, et al.. (2023). Inhibition of microRNA-34c reduces detrusor ROCK2 expression and urinary bladder inflammation in experimental cystitis. Life Sciences. 336. 122317–122317. 1 indexed citations
8.
Rakib, Ahmed, Mousumi Mandal, Sonia Kiran, et al.. (2023). Piceatannol induces regulatory T cells and modulates the inflammatory response and adipogenesis. Biomedicine & Pharmacotherapy. 161. 114514–114514. 12 indexed citations
9.
Regner, Kevin R., et al.. (2022). Cannabinoid Type 2 Receptor Activation Reduces the Progression of Kidney Fibrosis Using a Mouse Model of Unilateral Ureteral Obstruction. Cannabis and Cannabinoid Research. 7(6). 790–803. 10 indexed citations
10.
Potukuchi, Praveen K., Hamid Moradi, Frank Park, et al.. (2021). Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis. Cannabis and Cannabinoid Research. 8(1). 138–147. 5 indexed citations
11.
Hama, Taketsugu, Prashanth K.B. Nagesh, Pallabita Chowdhury, et al.. (2021). DNA damage is overcome by TRIP13 overexpression during cisplatin nephrotoxicity. JCI Insight. 6(22). 9 indexed citations
12.
Siricilla, Shajila, Katsuhiko Mitachi, Yuehong Wang, et al.. (2018). An antimycobacterial pleuromutilin analogue effective against dormant bacilli. Bioorganic & Medicinal Chemistry. 26(17). 4787–4796. 10 indexed citations
13.
Arnst, Kinsie E., Yuxi Wang, Dong‐Jin Hwang, et al.. (2017). A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance. Cancer Research. 78(1). 265–277. 100 indexed citations
14.
Alghamdi, Sahar S., Pankaj Pandey, Kuldeep K. Roy, et al.. (2017). Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury. Journal of Pharmacology and Experimental Therapeutics. 364(2). 287–299. 29 indexed citations
15.
16.
Noh, Yung‐Kyun, Frank Park, & Daniel D. Lee. (2012). Diffusion Decision Making for Adaptive k-Nearest Neighbor Classification. Neural Information Processing Systems. 25. 1925–1933. 5 indexed citations
17.
Šepac, Ana, Filip Sedlić, Karim Si‐Tayeb, et al.. (2010). Isoflurane Preconditioning Elicits Competent Endogenous Mechanisms of Protection from Oxidative Stress in Cardiomyocytes Derived from Human Embryonic Stem Cells. Anesthesiology. 113(4). 906–916. 42 indexed citations
18.
Park, Frank, William E. Sweeney, Benjamin Mueller, et al.. (2009). Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD. American Journal of Physiology-Renal Physiology. 296(3). F575–F582. 18 indexed citations
19.
Hattan, Naoichiro, et al.. (2007). Restoration of coronary collateral growth in the Zucker obese rat:. Basic Research in Cardiology. 102(3). 217–223. 40 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Belén Peral Breakdown of academic impact, for papers by Nicholas Obermüller Breakdown of academic impact, for papers by Osamu Yasuda Breakdown of academic impact, for papers by P. Darwin Bell Breakdown of academic impact, for papers by Kazuhiro Oka Breakdown of academic impact, for papers by Éva Kiss Breakdown of academic impact, for papers by Robert F. Spurney Breakdown of academic impact, for papers by Shinichi Usui Breakdown of academic impact, for papers by Florian Grahammer Breakdown of academic impact, for papers by John Li
Rankless by CCL
2026